FDA Authorizes Extra Doses Of Bivalent COVID-19 Vaccine For Immunocompromised Young Children

MedPage Today (4/28, Ingram) reported, “The FDA has authorized additional doses of Pfizer/BioNTech’s bivalent COVID-19 vaccine for young immunocompromised children.” Now, “in kids ages 6 months to 4 years with certain types of immunocompromising condition...